IGF1 and lymphedema: Although the therapeutic efficacy of MSCs in combination with LEPCs in lymphedema was initially demonstrated, the in vivo experiments still have some limitations, and it needs to be further verified whether MSCs exert the same pro-proliferative effect on LEPCs in vivo and whether IGF-1 mediates this process.